1) Aprazer Healthcare Launched SOFOKAST (Sofosbuvir 400 mg Tablets ) which is a medication used to treat hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir, daclatasvir, or velpatasvir.
2) Aprazer Healthcare Launched Dacikast (Daclatasvir 400 mg Tablets ) which is a medication used in combination with other medications to treat hepatitis C. The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis.
3) LEDIKAST (Ledipasvir 90mg & Sofosbuvir 400 mg Tablets ) which is a medication used to treat hepatitis C. It is a combination of ledipasvir and sofosbuvir & Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1.
4) VELAKAST (Velpatasvir & Sofosbuvir 400 mg Tablets ) is a fixed dose combination medication for the treatment of hepatitis C in adults. It combines sofosbuvir and velpatasvir. It is more than 90% effective for hepatitis C genotypes one through six.
Date: 10 MAY 2018